Download PDF
Thromb Haemost 1997; 78(01): 631-635
DOI: 10.1055/s-0038-1657602
Epidemiology of inherited thrombophilia
Schattauer GmbH Stuttgart

The Leiden Thrombophilia Study (LETS)

Felix J M van der Meer
1   Department of Hematology, Hemostasis and Thrombosis Research Center, Academic Hospital Leiden, The Netherlands
,
T Koster
2   Department of Clinical Epidemiology, Hemostasis and Thrombosis Research Center, Academic Hospital Leiden, The Netherlands
,
J P Vandenbroucke
2   Department of Clinical Epidemiology, Hemostasis and Thrombosis Research Center, Academic Hospital Leiden, The Netherlands
,
E Briët
1   Department of Hematology, Hemostasis and Thrombosis Research Center, Academic Hospital Leiden, The Netherlands
,
Frits R Rosendaal
1   Department of Hematology, Hemostasis and Thrombosis Research Center, Academic Hospital Leiden, The Netherlands
2   Department of Clinical Epidemiology, Hemostasis and Thrombosis Research Center, Academic Hospital Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-996
    CrossrefPubMedGoogle Scholar
  • 2 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
    CrossrefPubMedGoogle Scholar
  • 3 Bertina RM, Broekmans AW, Van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 01-05
    PubMedGoogle Scholar
  • 4 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism. A study in three Dutch families. N Engl J Med 1983; 309: 340-344
    CrossrefPubMedGoogle Scholar
  • 5 Koster T, Rosendaal FR, Briët E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85: 2756-2761
    PubMedGoogle Scholar
  • 6 Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525-1528
    CrossrefPubMedGoogle Scholar
  • 7 Broekmans AW, Bertina RM, Reinalda-Poot J, Engesser L, Muller HP, Leeuw JA, Michiels JJ, Brommer EJP, Briët E. Hereditary protein S deficiency and venous thromboembolism. A study in three Dutch families. Thromb Haemost 1985; 53: 273-277
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Engesser L, Broekmans AW, Briët E, Brommer EJP, Bertina RM. Hereditaiy protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-682
    CrossrefPubMedGoogle Scholar
  • 9 Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-1516
    CrossrefPubMedGoogle Scholar
  • 10 Tait RC, Walker ID, Perry DJ, Islam SIAM, Daly ME, McCall F, Conkie JA, Carrell RW. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-112
    CrossrefPubMedGoogle Scholar
  • 11 Koster T, Rosendaal FR, De Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 12 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden RA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 13 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-1508
    PubMedGoogle Scholar
  • 14 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
    CrossrefPubMedGoogle Scholar
  • 15 Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP. Lancet 1995; 346: 1593-1596
    CrossrefPubMed
  • 16 Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Lancet 1995; 345: 152-155
    CrossrefPubMed
  • 17 Den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762
    CrossrefPubMedGoogle Scholar
  • 18 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703
    PubMedGoogle Scholar